Europe
Animal Healthcare Market, By Animal Type (Livestock Animals and Companion
Animal), By Route of Administration (Oral, Topical, and Injectable), By
Indication (Infectious Disease, Pain, Autoimmune Disease, and Others), and by
Country (U.K., Germany, France, Spain, Russia, Switzerland, Netherlands, Italy,
and Rest of Europe), is estimated to be
valued at US$ 13,119.7 million in 2020 and is expected to exhibit a CAGR of
4.5% over the forecast period (2020-2027), as highlighted in a new report
published by Coherent Market Insights.
Increasing approvals and launches
by market players is expected to augment the market growth
Key players in the market are
focused on launches and approvals of products in order to provide affordable
treatment options, which is expected to propel growth of the market. For
instance, in April 2019, Vetoquinol S.A. launched Flexprofen, a generic
chewable tablet consisting of carprofen, which acts as a non-steroidal
anti-inflammatory (NSAID) for treatment of dogs suffering from postoperative
pain due to orthopedic surgeries. Moreover, in September 2015, Oculus
Innovative Sciences, Inc. launched MicrocynAH Anti-Itch Spray Gel and
MicrocynAH Hot Spot Spray Gel, which helps in relieving itchiness and pain
associated with skin diseases in animals such as dogs, cats, horses, rabbits,
and livestock.
Increasing transmission of
zoonotic pathogens to humans working in close proximity of infected animals is
expected to aid in growth of the Europe animal healthcare market. Europe has
witnessed a substantial increase in zoonotic diseases, which has led to high
demand for animal vaccines in the region. For instance, according to the
European Centre for Disease Prevention and Control (ECDC), in 2017, around 381
cases of brucellosis were reported in Europe, in which Greece, Italy, and Spain
accounted for around 67.2% of all brucellosis cases reported in Europe.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/550
Global Europe Animal Healthcare
Market – Impact of Coronavirus (Covid-19) Pandemic
The Food and Agriculture
Organization of the United Nations provided guidelines to mitigate the impact
of the COVID-19 pandemic on livestock production and animal health, which
included the following recommendations for the livestock farmers to prevent
spread of the coronavirus infection:
Communication with professional
service providers such as milk collectors, and suppliers of feed and
consumables should be established to find solutions to secure supplies, inputs,
and services
Communication through producer
cooperatives or farmers associations for obtaining necessary exemptions for
mobilization of animals, products, and personnel
Explore alternative sales
channels such as online sales, e-commerce, and direct sales, and use
point-to-point transportation to deliver livestock and related products to
buyers
The farmers should obtain latest
information on the evolving COVID-19 situation from trusted sources such as
radio programs provided by local governments, official news releases, livestock
market officers, veterinary pharmacies, farmers associations, and others
Implementation of practical biosafety
and biosecurity measures to prevent human contamination with COVID-19 in the
farm. These measures include:
Installation of footbaths and
changing the disinfectant frequently
A designated area should be
maintained for external visitors; visitor interactions with farm workers should
be restricted
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/animal-healthcare-market-550
Consultation with animal health
professionals to improve biosecurity and biosafety in the farm
Browse 38 Market Data Tables and
27 Figures spread through 183 Pages and in-depth TOC on “Europe Animal Healthcare
Market - By Animal Type (Livestock Animals and Companion Animal), By Route of
Administration (Oral, Topical, and Injectable), By Indication (Infectious
Disease, Pain, Autoimmune Disease, and Others), and by Country (U.K., Germany,
France, Spain, Russia, Switzerland, Netherlands, Italy, and Rest of
Europe) - Global Forecast to 2027”
Furthermore, increasing number of
partnerships and collaborations among market players for the development of new
products and rising awareness regarding animal health are expected to drive the
market growth over the forecast period. For instance, in March 2017, Boehringer
Ingelheim Animal Health and Novozymes entered into a strategic agreement for
the development and commercialization of probiotic products for poultry
production.
Key Takeaways of the Europe
Animal Healthcare Market:
The Europe animal healthcare
market is expected to exhibit a CAGR of 4.5% over the forecast period, owing to
increasing animal population such as dogs, cats, cattle, and others, thereby
driving demand for animal healthcare services. For instance, according to
PetSecure, a pet insurance provider, there were around 7,570,000 dogs and
11,480,000 cats in France during 2017-2018.
Among animal type, the livestock
animal segment held a dominant position in the Europe animal healthcare market
in 2018. The major driver for growth of the segment is increasing number of
livestock animals in Europe, owing to rising demand for animal protein products
such as milk and meat. For instance, according to the Food and Agricultural
Organization of the United Nation, in 2018, the sheep population increased from
1,098,662 in 2006 to 1,173,354 in 2016.
Among route of administration,
the oral segment held a dominant position in the Europe animal healthcare
market in 2018, owing to increasing number of partnerships and collaborations
for development of new products and rising awareness about animal health. For
instance, in February 2019, ECO Animal Health Ltd., a subsidiary of ECO Animal
Health Group plc, entered into a worldwide exclusive poultry vaccine
development and licensing deal with Ghent University.
Companies operating in the Europe
animal healthcare market include Merck & Co., Inc., Virbac, Dechra
Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer
AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/550
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment